Tomasz Trzeciak

Tomasz Trzeciak

Auto-generated profile, based on publicly available information

Tomasz Trzeciak

Department of Orthopaedics and Traumatology, Poznan University of Medical Sciences, 28 Czerwca 1956r. 135/147 Street, 61-545, Poznan, Poland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2015 in Annals of Biomedical Engineering
Verified
Journal Article
Open access
PDF file
WSWiktoria Suchorska
Wiktoria Suchorska
MLMichał Stefan Lach
Michał Stefan Lach
MRMagdalena Richter
Magdalena Richter
JKJacek Kaczmarczyk
Jacek Kaczmarczyk
TTTomasz Trzeciak
Tomasz Trzeciak
To improve the recovery of damaged cartilage tissue, pluripotent stem cell-based therapies are being intensively explored. A number of techniques exist that enable monitoring of stem cell differentiation, including immunofluorescence staining. This simple and fast method enables changes to be observed during the differentiation process. Here, two protocols for the differentiation of human embryonic stem cells into chondrocytes were used (monolayer cell culture and embryoid body formation). Cells were labeled for markers expressed during the differentiation process at different time points (pluripotent: NANOG, SOX2, OCT3/4, E-cadherin; prochondrogenic: SOX6, SOX9, Collagen type II; extracellular matrix components: chondroitin sulfate, heparan sulfate; beta-catenin, CXCR4, and Brachyury). Comparison of the signal intensity of differentiated cells to control cell populations (articular cartilage chondrocytes and human embryonic stem cells) showed decreased signal intensities of pluripotent markers, E-cadherin and beta-catenin. Increased signal intensities of prochondrogenic markers and extracellular matrix components were observed. The changes during chondrogenic differentiation monitored by evaluation of pluripotent and chondrogenic markers signal intensity were described. The changes were similar to several studies over chondrogenesis. These results were confirmed by semi-quantitative analysis of IF signals. In this research we indicate a bioimaging as a useful tool to monitor and semi-quantify the IF pictures during the differentiation of hES into chondrocyte-like.

11 July 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
MRMonika Anna Rosochowicz
Monika Anna Rosochowicz
MLMichał Stefan Lach
Michał Stefan Lach
MRMagdalena Richter
Magdalena Richter
IJInga Jagiełło
Inga Jagiełło
WSWiktoria Suchorska
Wiktoria Suchorska
TTTomasz Trzeciak
Tomasz Trzeciak
Background: One of the obstacles to autologous chondrocyte implantation (ACI) is obtaining a large quantity of chondrocytes without depletion of their properties. The conditioned medium (CM) from different subpopulations of stem cells (mesenchymal stromal cells (MSC) or induced pluripotent stem cells (iPSC)) could be a gamechanger. MSCs' potential is related to the donor's health and age, which could be omitted when, as a source, iPSCs are used. There is a lack of data regarding their use in the chondrocyte culture expansion. Thus, we wanted to verify whether iPSC-CM could be beneficial for the cell culture of primary chondrocyte cells. Methods: We added the iPSC-CMs from GPCCi001-A and ND 41658*H cells to the culture of primary chondrocyte cell lines isolated from OA patients (n = 6) for other two passages. The composition of the CM was evaluated using Luminex technology. Then, we analysed the senescence, proliferation rate and using flow cytometry: viability, distribution of cell cycle phases, production of reactive oxygen species (ROS) and double-strand breaks. The cartilage-related markers were evaluated using Western blot and immunofluorescence. Additionally, a three-dimensional cell culture was used to determine the potential to form cartilage particles. Results: iPSC-CM increased proliferation and diminished cell ROS production and senescence. CM influenced the cartilage-related protein expression and promoted the growth of cartilage particles. The cell exposed to CM did not lose the ECM proteins, suggesting the chondroprotective effect for prolonged culture time. Conclusion: Our preliminary results suggest a beneficial effect on maintaining chondrocyte biology during in vitro expansion.

15 July 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
MRMonika Anna Rosochowicz
Monika Anna Rosochowicz
MLMichał Stefan Lach
Michał Stefan Lach
MRMagdalena Richter
Magdalena Richter
WSWiktoria Suchorska
Wiktoria Suchorska
TTTomasz Trzeciak
Tomasz Trzeciak
Knee osteoarthritis (OA) affects approximately 13-17 % of adults over 40 in Europe, making it the most prevalent musculoskeletal disorder. Cell-based therapies for OA but are limited by the pro-inflammatory OA environment, which may affect cell senescence, dedifferentiation, and fibrocartilage formation, which impact clinical outcomes. Conditioned medium (CM) from cells, particularly iPSCs, is a promising source due to their remarkable regenerative abilities. This study aims to explore the chondroprotective effects of iPSC-derived CM on chondrocytes cultured in an OA-like environment using synovial fluid (SF) from OA patients. CM was collected from iPSC lines (GPCCi001-A and ND 41658∗H) the day before and on the day of passage, then centrifuged, and pooled to create a homogeneous environment. CMs were mixed 1:1 with standard chondrogenic medium and/or 10 % SF pooled from knee OA joints (n = 27, Kellgren-Lawrence 3 and 4), creating CM + SF mixtures. Controls included standard chondrogenic medium and SF alone. These media were added to a primary chondrocyte line culture. Cellular responses to treatment were assessed through proliferation, senescence, viability, oxidative stress, and expression of key cartilage and inflammation-related markers. CMs, alone or with SF, enhanced proliferation (ANOVA - p < 0.0001) and reduced the senescent cell percentage (Young: p = 0.0044; Senescent: p = 0.0021) compared to controls. Viability (Live: p = 0.5422; Dead: p = 0.3914) and cell cycle phase distribution (SubG1: p = 0.0246; G1/G0: p = 0.6380; S: p = 0.8555; G2/M: p = 0.5811) were not affected. ROS production was significantly lower in CM + SF cultures (p = 0.0070). CM and CM + SF have caused a considerable decline in COL1A1 (p = 0.1756), COMP (p = 0.0062), and COL10A1 (p = 0.0250) production and an increasing trend in ACAN (p = 0.2032), NFκB (p = 0.0402), Bax (p = 0.3340) and p21 (p = 0.0002) expression. iPSC-derived CM is non-toxic and may promote chondrocyte metabolic activity, reduce ROS levels, and mitigate the inflammatory effects of OA-derived SF.